John Libbey Eurotext

L'Information Psychiatrique

Contexte et développement d’un programme de prise en charge des psychoses émergentes : Ecotone Volume 93, numéro 5, Mai 2017

  • [1] American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5). Washington: American Psychiatric; 2013.
  • [2] Fusar-Poli P., Borgwardt S., Bechdolf A. The Psychosis High-Risk State. JAMA Psychiatry. 2013;70:107.
  • [3] Marion-Veyron R., Mebdouhi N., Baumann P. Les premiers épisodes psychotiques : de l’importance du . Evolution Psychiatrique. 2013;78:41-51. case management
  • [4] McGorry P., Killackey E., Yung A. Early intervention in psychosis : concepts, evidence and future directions. World Psychiatry. 2008;7:148-156.
  • [5] Robinson D.G., Woerner M.G., McMeniman M., Mendelowitz A., Bilder R.M. Symptomatic and functionnal recovery from a first episode of schizophrenia or schizoaffective disorder. American Journal of Psychiatry. 2004;161:473-479.
  • [6] Haefner H., Maurer K. Early detection of schizophrenia : current evidence and future perspectives. World Psychiatry. 2006;5:130.
  • [7] Penttilä M., Jääskelaïnen E., Hirvonen N., Isohanni M., Miettunen J. Duration of untreated psychosis as predictor of long-term outcome in schizophrenia : systematic review and meta-analysis. The British Journal of Psychiatry. 2014;205:88-94.
  • [8] Schimmelmann B.G., Huber C.G., Lambert M., Cotton S., McGorry P.D., Conus P. Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort. Journal of Psychiatric Research. 2008;42:982-990.
  • [9] International early psychosis association writing group. International clinical practice guidelines for early psychosis. The British Journal of Psychiatry. 2005;187:S120-S124.
  • [10] Conus P., Polari A., Bonsack C. Intervention dans la phase précoce des troubles psychotiques : objectifs et organisation du programme TIPP (Traitement et intervention dans la phase précoce des troubles psychotiques) à Lausanne. L’Information Psychiatrique. 2010;86:145-151.
  • [11] Leucht S., Cipriani A., Spineli L. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. The Lancet. 2013;382:951-962.
  • [12] Pachoud B., Allemand C. Le soutien à l’emploi (ou les pratiques de «  ») : une nouvelle stratégie d’insertion professionnelle des personnes en situation de handicap psychique. L’évolution Psychiatrique. 2013;78:107-117. job coaching
  • [13] Addington D., Addington M.D., Patten S. Relapse rates in an early psychosis treatment service. Acta Psychiatrica Scandinavia. 2007;115:126-131.
  • [14] Jacob B., Macquet D., Natalis S. A global reform of mental health care based on a community approach : the Belgian experience/Une réforme globale des soins en santé mentale basée sur une approche communautaire : l’experience belge. Santé mentale au Quebec. 2014;39:209-243.
  • [15] OECD. Meantal Health and Work : Belgium, Mental Health and Work. Paris: OECD Publishing; 2013.
  • [16] Fusar-Poli P., Bonoldi I., Yung A.R. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Archives of General Psychiatry. 2012;69:220-229.
  • [17] Keshavan M.S., Nasrallah H.A., Tandon R. Schizophrenia,“Just the Facts” 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse. Schizophrenia research. 2011;127:3-13.
  • [18] Demazeux S. Les catégories psychiatriques sont-elles dépassées ? Philonsorbonne. 2008;2:67-88.
  • [19] Guelfi J.D. L’avenir des classifications des psychoses chez l’adulte. L’information psychiatrique. 2010;86:127-134.
  • [20] Shrivastava A., McGorry P.D., Tsuang M. “Attenuated psychotic symptoms syndrome” as a risk syndrome of psychosis, diagnosis in DSM-V : The debate. Indian Journal of Psychiatry. 2011;53:57.
  • [21] Parnas J., Nordgaard J., Varga S. The concept os psychosis : A clinical and theoretical analysis. Clinical Neuropsychiatry. 2010;7:3247.
  • [22] Craddock N., Owen M.J. The Kraepelinian dichotomy – going, going… but still not gone. The British Journal of Psychiatry. 2010;196:92-95.
  • [23] Van Os J., Reininghaus U. Psychosis as a transdiagnostic and extended phenotype in the general population. World Psychiatry. 2016;15:118-212.
  • [24] Parnas J., Møller P., Kircher T. EASE: examination of anomalous self-experience. L’Encéphale. 2012;38:S121-S145.
  • [25] Sass L.A., Self-disturbance, schizophrenia:. Structure, specificity, pathogenesis (Current issues, New directions). Schizophrenia research. 2014;152:5-11.
  • [26] Abi-Dargham, Anissa. Do we still believe in the dopamine hypothesis? New data bring new evidence. International Journal of Neuropsychopharmacology. 2004;7:S1-S5.
  • [27] Kendler K.S., Schaffner K.F. The dopamine hypothesis of schizophrenia : an historical and philosophical analysis. Philosophy, Psychiatry, & Psychology. 2011;18:41-63.
  • [28] Zohar J., Nutt D.J., Kupfer D.J. A proposal for an updated neuropsychopharmacological nomenclature. European Neuropsychopharmacology. 2014;24:1005-1014.
  • [29] Harrow M., Jobe T.H. Does long-term treatment of schizophrenia with antipsychotic medications facilitate recovery? Schizophrenia bulletin. 2013;39:962-965.
  • [30] Martin B., Wittmann M., Franck N. Temporal structure of consciousness and minimal self in schizophrenia. Frontiers in psychology. 2014;5.